The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg
about
Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update.Valsartan combination therapy in the management of hypertension - patient perspectives and clinical utilityMeta-analysis of the efficacy and safety of adding an angiotensin receptor blocker (ARB) to a calcium channel blocker (CCB) following ineffective CCB monotherapy.Valsartan 160 mg/Amlodipine 5 mg Combination Therapy versus Amlodipine 10 mg in Hypertensive Patients with Inadequate Response to Amlodipine 5 mg MonotherapyModerate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy.Angiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapy.Complementary mechanisms of angiotensin receptor blockers and calcium channel blockers in managing hypertension.Efficacy and safety of angiotensin II type 1 receptor blocker/calcium channel blocker combination therapy for hypertension: focus on a single-pill fixed-dose combination of valsartan and amlodipine.Indirect treatment comparison between fixed-dose-combinations of amlodipine/losartan and amlodipine/valsartan in blood pressure control.High-dose calcium channel blocker (CCB) monotherapy vs combination therapy of standard-dose CCBs and angiotensin receptor blockers for hypertension: a meta-analysis.Real-life safety and effectiveness of amlodipine/valsartan combination in the treatment of hypertension.Rationale and design of the Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) trial.Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study.Application of an LC-MS/MS method for the analysis of amlodipine, valsartan and hydrochlorothiazide in polypill for a bioequivalence study.
P2860
Q33797646-77F48F06-7C37-43F4-92F4-4F80E608CF41Q35210583-86E860EC-2A23-42C2-B770-A46DE3B2F283Q36437458-9578DEEC-83D9-4187-84DF-FFCA61AD7712Q36723503-829D68C5-3617-4754-829D-3DD3F2E205FFQ36929276-53ECC850-550A-4E12-8F43-24501F680507Q37427232-6DA002EA-C444-43D7-8866-297333DF60E8Q37427235-B708212D-2178-4D3F-B3F4-0CE4E35BADEDQ37994857-688768B7-0059-4202-A346-103AA23D9E1BQ38181586-3EDEF89F-1BF4-477A-8069-D9EC09B9D32CQ38832512-363AEEF4-BCF5-4CB3-8939-28712F79B226Q38940759-2955FDAC-0E6B-4CDB-97E1-2A815C6C1197Q39316867-07572017-5AA0-4F86-B08B-8C3B08CC3822Q40932548-12C13B7D-54C0-49C3-9ABC-3C1AB08400CEQ49211738-009B99CA-EEFD-46DE-A06F-FBCFAA4AC7A9
P2860
The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The combination of amlodipine/ ...... ontrolled with amlodipine 5 mg
@en
The combination of amlodipine/ ...... ntrolled with amlodipine 5 mg.
@nl
type
label
The combination of amlodipine/ ...... ontrolled with amlodipine 5 mg
@en
The combination of amlodipine/ ...... ntrolled with amlodipine 5 mg.
@nl
prefLabel
The combination of amlodipine/ ...... ontrolled with amlodipine 5 mg
@en
The combination of amlodipine/ ...... ntrolled with amlodipine 5 mg.
@nl
P2093
P2860
P1476
The combination of amlodipine/ ...... ontrolled with amlodipine 5 mg
@en
P2093
A Salvetti
J Schrader
M Weisskopf
P2860
P304
P356
10.1111/J.1742-1241.2008.01977.X
P577
2009-02-01T00:00:00Z